7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2010-12-31 2009-12-31 
      
                                                            
      cash flows from operating activities:
                                                            
      net earnings
    231,200,000 153,400,000 182,600,000  249,200,000 243,100,000 172,800,000         -83,900,000 145,800,000 142,500,000 197,700,000 333,800,000 246,100,000 -208,200,000 -509,100,000 321,400,000 432,000,000 131,900,000 246,200,000 -902,500,000 162,100,000 184,900,000 176,200,000 1,231,200,000 299,300,000 69,700,000 157,900,000 -28,800,000 105,800,000 126,700,000 900,000 -158,200,000 176,800,000 156,500,000 165,300,000 176,100,000 221,100,000 235,400,000 154,100,000 151,700,000 218,000,000 152,300,000 177,700,000 214,000,000 208,900,000 156,100,000   
      adjustments to reconcile net earnings to cash from operating activities:
                                                            
      depreciation and amortization
    283,600,000 271,800,000 254,400,000 263,600,000 250,900,000 243,200,000 238,600,000 241,200,000 241,200,000 237,500,000 231,800,000 228,500,000 231,400,000 232,700,000 233,800,000 267,100,000 265,100,000 266,500,000 268,700,000 265,400,000 258,600,000 255,700,000 253,000,000 253,900,000 251,500,000 253,000,000 247,700,000 254,800,000 260,600,000 261,600,000 263,500,000 264,500,000 267,600,000 252,000,000 288,100,000 252,300,000 246,900,000 284,300,000 239,500,000 99,600,000 89,000,000 92,600,000 90,900,000 91,300,000 101,000,000 90,100,000 91,900,000 91,400,000 85,100,000 90,200,000 82,700,000 93,400,000 96,800,000 94,300,000 90,700,000 87,800,000 
      share-based compensation
    25,300,000 21,200,000 19,600,000 21,100,000 24,500,000 26,400,000 29,000,000 25,300,000 15,600,000 33,900,000 25,000,000 26,800,000 27,400,000 27,600,000 23,200,000 17,700,000 21,200,000 24,800,000 21,600,000 17,700,000 23,700,000 21,800,000 16,500,000 22,700,000 21,600,000 19,700,000 20,300,000 20,200,000 19,300,000 12,100,000 13,900,000 13,600,000 14,000,000 11,400,000 15,200,000 18,000,000 12,700,000 11,700,000 13,500,000 8,300,000 12,900,000 12,400,000 12,800,000 13,000,000 11,200,000 11,400,000 10,900,000 12,200,000 14,000,000 13,300,000 13,900,000 15,000,000 12,800,000 14,400,000 16,600,000 17,600,000 
      changes in operating assets and liabilities, net of acquired assets and liabilities
                                                            
      income taxes
    -42,700,000 -116,400,000 -15,600,000 22,600,000 -76,700,000 -95,900,000 -8,600,000 -97,200,000 9,600,000 -7,700,000 21,500,000 -140,500,000 -25,400,000 15,500,000 -2,500,000 -48,400,000 -37,500,000 -27,800,000 -9,500,000 -236,100,000 -8,900,000 -700,000 -45,400,000 467,700,000 -312,100,000 -68,700,000 24,500,000 -92,500,000 -15,900,000 -51,000,000 8,600,000 395,600,000 -86,900,000 141,300,000 -165,800,000 54,400,000 -40,800,000 133,400,000 -600,000 43,800,000 -13,300,000  -19,900,000 -38,800,000 -75,600,000  -2,400,000 -65,400,000 17,600,000  19,100,000 -37,200,000 47,800,000    
      receivables
    3,000,000 200,000 -18,800,000 -49,600,000 -29,900,000 12,500,000 -22,700,000 -67,400,000 7,500,000 -600,000 8,600,000 -70,200,000 -32,700,000 -67,600,000 -14,200,000 -33,000,000 12,600,000 -38,300,000 43,600,000 -83,600,000 -259,100,000 -17,000,000 289,700,000 -203,300,000 80,200,000 -21,400,000 50,700,000 -23,800,000 59,700,000 31,500,000 146,200,000 -173,200,000 26,800,000 -57,500,000 40,500,000 -37,400,000 -83,400,000 -85,500,000 88,700,000 -65,900,000 6,600,000 1,900,000 -27,600,000 -20,000,000 5,300,000 -41,300,000 57,000,000 -45,800,000 -44,200,000 -11,300,000 52,700,000 -32,700,000 -54,200,000 -23,500,000 -19,900,000 -15,500,000 
      inventories
    -46,000,000 -37,200,000 -3,000,000 87,900,000 3,800,000 13,500,000 -55,300,000 -28,200,000 -64,200,000 -53,800,000 -94,200,000 -12,100,000 -37,100,000 -25,800,000 -600,000 113,400,000 -200,000 -8,300,000 -86,100,000 67,800,000 14,000,000 -26,600,000 -96,000,000 -19,200,000 -23,000,000 -32,300,000 -50,700,000 -34,300,000 -65,900,000 -59,600,000 -39,700,000 400,000 -11,500,000 32,200,000 -16,000,000 21,900,000 38,300,000 -8,900,000 -46,600,000 -87,700,000 -62,200,000 -19,900,000 -49,000,000 -28,600,000 -56,600,000 -13,300,000 -28,900,000 -26,500,000 -59,700,000 -14,200,000 -23,600,000 -23,700,000 -6,000,000 34,900,000 18,900,000 58,500,000 
      accounts payable and accrued liabilities
    -51,500,000 76,800,000 -36,400,000 -117,300,000 -23,200,000 -62,100,000 -119,400,000 164,200,000 -34,300,000 -93,400,000 -91,800,000 104,600,000 48,300,000 -34,000,000 -15,900,000 83,500,000 49,200,000 104,900,000 -161,200,000 36,300,000 102,500,000 -138,100,000 -95,800,000 120,700,000 107,100,000 -38,400,000 -231,400,000                              
      other assets and liabilities
    15,800,000 8,400,000 -100,000 85,500,000 -2,800,000 -11,300,000 -6,400,000 27,200,000 -700,000 22,200,000 -23,500,000 -104,700,000 44,700,000 40,100,000 18,700,000 33,900,000 -23,100,000 -26,700,000 -28,300,000 11,800,000 4,400,000 27,300,000 26,000,000 -1,900,000 20,600,000 -12,900,000 -23,700,000 36,000,000 9,700,000 13,300,000 -50,600,000 148,800,000 -111,500,000 175,700,000 -74,500,000 -25,900,000 -54,100,000 1,900,000 64,100,000 -110,000,000 22,200,000 -4,600,000 71,400,000 -300,000 21,100,000 -55,800,000 14,800,000 23,800,000 -29,900,000 30,300,000 500,000 -13,400,000 -74,800,000 64,400,000 -17,700,000 10,600,000 
      net cash from operating activities
    418,700,000 378,200,000 382,800,000  395,700,000 369,400,000 228,000,000     7,000,000 -78,500,000 365,700,000 433,100,000 453,900,000 246,500,000 425,100,000 381,300,000 -52,800,000 450,900,000 423,300,000 577,900,000 301,000,000 283,600,000 379,500,000 484,100,000 393,300,000 490,500,000 402,900,000 275,400,000 627,200,000 352,600,000 387,200,000 265,200,000 387,100,000 151,300,000 186,800,000 91,500,000 354,200,000 255,700,000 254,100,000 188,800,000 300,200,000 292,700,000 189,700,000 180,500,000 368,000,000 345,000,000 231,500,000 207,400,000 393,100,000 341,000,000 385,500,000 
      capex
    -55,000,000 -50,100,000 -44,600,000  -44,500,000 -52,700,000 -55,100,000     -63,400,000 -47,200,000 -40,900,000 -36,400,000 -63,100,000 -54,200,000 -27,300,000 -27,400,000 -27,700,000 -30,600,000 -19,000,000 -40,200,000 -51,800,000 -58,600,000 -58,900,000 -37,800,000 -47,500,000 -61,500,000 -27,000,000 -26,700,000 -46,200,000 -43,100,000 -54,600,000 -56,400,000 -46,100,000 -27,600,000 -49,100,000 -53,800,000 -30,400,000 -34,400,000 -49,200,000 -32,300,000 -32,000,000 -31,400,000 -22,800,000 -36,900,000 -22,400,000 -17,900,000 -43,300,000 -27,100,000 -24,800,000 -19,500,000 -46,000,000 -38,600,000 -28,300,000 
      free cash flows
    363,700,000 328,100,000 338,200,000  351,200,000 316,700,000 172,900,000     -63,400,000 -47,200,000 -33,900,000 -114,900,000 302,600,000 378,900,000 426,600,000 219,100,000 397,400,000 350,700,000 -71,800,000 410,700,000 371,500,000 519,300,000 242,100,000 245,800,000 332,000,000 422,600,000 366,300,000 463,800,000 356,700,000 232,300,000 572,600,000 296,200,000 341,100,000 237,600,000 338,000,000 97,500,000 156,400,000 57,100,000 305,000,000 223,400,000 222,100,000 157,400,000 277,400,000 255,800,000 167,300,000 162,600,000 324,700,000 317,900,000 206,700,000 187,900,000 347,100,000 302,400,000 357,200,000 
      cash flows from investing activities:
                                                            
      additions to instruments
    -86,000,000 -80,500,000 -59,700,000 -51,900,000 -41,200,000 -65,200,000 -82,000,000 -78,900,000 -64,500,000 -85,500,000 -82,800,000 -66,100,000 -71,600,000 -64,200,000 -56,400,000 -78,900,000 -72,400,000 -67,900,000 -82,600,000 -68,900,000 -63,500,000 -73,600,000 -85,700,000 -76,400,000 -94,700,000 -81,100,000 -63,700,000 -72,600,000 -77,600,000 -65,700,000 -60,400,000 -81,300,000 -86,400,000 -94,200,000 -94,000,000 -72,200,000 -85,100,000 -80,400,000 -82,000,000 -41,600,000 -62,400,000 -34,500,000 -50,900,000 -62,600,000 -49,400,000 -26,800,000 -49,800,000 -58,800,000 -57,500,000 -44,200,000 -36,400,000 -39,500,000 -28,800,000 -26,500,000 -59,400,000 -21,000,000 
      additions to other property, plant and equipment
    -55,000,000 -50,100,000 -44,600,000 -51,500,000 -44,500,000 -52,700,000 -55,100,000 -62,800,000 -84,300,000 -97,300,000 -46,700,000 -63,400,000 -47,200,000 -40,900,000 -36,400,000 -63,100,000 -54,200,000 -27,300,000 -27,400,000 -27,700,000 -30,600,000 -19,000,000 -40,200,000 -51,800,000 -58,600,000 -58,900,000 -37,800,000 -47,500,000 -61,500,000 -27,000,000 -26,700,000 -46,200,000 -43,100,000 -54,600,000 -56,400,000 -46,100,000 -27,600,000 -49,100,000 -53,800,000 -30,400,000 -34,400,000 -49,200,000 -32,300,000 -32,000,000 -31,400,000 -22,800,000 -36,900,000 -22,400,000 -17,900,000 -43,300,000 -27,100,000 -24,800,000 -19,500,000 -46,000,000 -38,600,000 -28,300,000 
      net investment hedge settlements
    -8,800,000 2,500,000 1,000,000 2,800,000 2,800,000 6,300,000 10,200,000 6,200,000 8,200,000 5,600,000 13,400,000 18,200,000 37,300,000 21,200,000 12,700,000 4,300,000 7,200,000 -12,700,000 3,100,000 10,500,000 16,200,000 10,500,000 16,300,000 10,600,000 16,200,000 10,800,000 10,500,000                              
      business combination investments, net of acquired cash
      -160,000,000 -49,800,000   -102,000,000 -14,000,000 -18,900,000                                            
      acquisition of intangible assets
    -10,000,000 -30,000,000 -2,400,000 -33,400,000                                                     
      other investing activities
    -3,500,000 -300,000 2,800,000   -55,600,000 16,800,000 -12,000,000 21,300,000 -14,300,000  -3,700,000 -59,500,000 -1,000,000  -5,800,000            200,000 -900,000 -14,600,000  -3,600,000                        
      net cash from investing activities
    -163,300,000 -1,384,400,000 -106,000,000  -154,900,000 -247,000,000 -195,000,000     -7,200,000 -146,200,000 -125,200,000 -109,900,000 -122,300,000 -315,900,000 -91,400,000 -85,300,000 -121,200,000 -138,000,000 -163,600,000 -322,200,000 -105,500,000 -82,400,000 -138,900,000 -93,600,000 -101,700,000 -128,200,000 -133,100,000 -146,800,000 -1,374,300,000 -266,200,000 95,800,000 121,500,000 41,300,000 -7,788,600,000 67,900,000 28,700,000 -229,400,000 -170,300,000 -98,400,000 -10,200,000 -150,700,000 -174,600,000 53,000,000 -224,600,000 -85,400,000 -117,900,000 -164,200,000 -213,300,000 -491,500,000 -133,300,000 
      cash flows from financing activities:
                                                            
      net payments on revolving facilities
                                                            
      proceeds from senior notes
    744,000,000 1,748,100,000 736,300,000                1,497,100,000     749,500,000        7,628,200,000                
      redemption of senior notes
    -863,000,000     -86,300,000 -525,800,000 -750,000,000 -2,154,800,000 -300,000,000 -200,000,000 -250,000,000                                
      dividends paid to stockholders
    -47,500,000 -47,500,000 -47,800,000 -48,000,000 -49,200,000 -49,400,000 -49,400,000 -50,200,000 -50,100,000 -50,300,000 -50,300,000 -50,400,000 -50,300,000 -50,300,000 -50,200,000 -50,200,000 -50,100,000 -50,000,000 -49,800,000 -49,800,000 -49,600,000 -49,600,000 -49,500,000 -49,400,000 -49,200,000 -49,100,000 -49,000,000 -49,000,000 -48,800,000 -48,800,000 -48,600,000 -48,600,000 -48,100,000 -48,100,000 -47,900,000 -47,800,000 -44,600,000 -44,800,000 -37,600,000 -37,400,000 -37,300,000 -37,500,000 -37,100,000 -36,900,000 -34,000,000 -34,000,000 -33,900,000 -33,600,000 -30,900,000 -31,200,000 -31,500,000      
      proceeds from employee stock compensation plans
    20,900,000 400,000 16,700,000 500,000 18,600,000 6,600,000 56,400,000 19,300,000 20,700,000 25,100,000 36,000,000 14,900,000 18,200,000 4,500,000 40,500,000 5,200,000 25,800,000 26,200,000 65,300,000 32,100,000 36,000,000 7,200,000 54,500,000 32,300,000 71,100,000 10,400,000 44,400,000 4,500,000 47,000,000 8,500,000 47,900,000 12,900,000 66,100,000 23,100,000 34,900,000 47,300,000 31,300,000 28,200,000 42,400,000 7,100,000 27,500,000 30,200,000 35,600,000 80,700,000 138,200,000 149,400,000 108,700,000 149,700,000 67,000,000 12,800,000 16,100,000 7,700,000 10,300,000 9,400,000 4,000,000 1,900,000 
      business combination contingent consideration payments
    -7,600,000 -17,400,000 -2,000,000 -1,500,000 -700,000 -9,600,000     -2,400,000 -700,000 -5,800,000 -2,000,000 -5,500,000 -4,000,000 -3,500,000     -3,100,000 -3,100,000 -13,600,000 -6,000,000                        
      debt issuance costs
    -5,400,000 -1,200,000 -16,100,000             -11,700,000    -2,900,000 -7,200,000 -12,200,000      -4,900,000  -6,600,000    -58,400,000 -16,400,000            
      deferred business combination payments
        -1,000,000 -6,300,000 -1,500,000       -45,000,000                                         
      repurchase of common stock
    -7,200,000 -229,800,000 -72,200,000 -596,300,000 -85,900,000 -113,600,000 -410,300,000 -14,300,000 -267,600,000                       -415,500,000     -400,500,000 -240,700,000 -17,500,000 -68,800,000 -392,000,000 -139,900,000 -97,600,000 -106,500,000 -141,600,000 -143,500,000 -101,000,000 -519,300,000 
      other financing activities
    -500,000 -900,000 -15,200,000 -3,000,000 -6,900,000 -2,000,000 -10,500,000 700,000 -1,600,000 -100,000 -5,100,000 900,000 -1,900,000 -200,000 -3,300,000 3,300,000 -300,000 -3,800,000 -5,500,000 -1,600,000 -600,000 -100,000 -6,000,000 -4,800,000 -500,000 -700,000 -4,200,000                              
      net cash from financing activities
    483,800,000 163,800,000 575,400,000  -101,900,000 -91,900,000 -50,100,000     -68,100,000 -655,800,000 -426,100,000 -28,300,000 -195,800,000 -286,300,000 -42,600,000 -1,585,700,000 1,492,800,000 -182,700,000 -298,400,000 -163,600,000 -135,200,000 -275,500,000 -297,700,000 -1,570,800,000 841,800,000 -232,900,000 256,100,000 -309,100,000 519,200,000 -128,000,000 -825,300,000 -515,800,000 -144,100,000 231,100,000 7,568,600,000 -255,400,000 -15,900,000 -400,000 -290,700,000 -122,200,000 60,300,000 47,100,000 -452,500,000 -58,100,000 -116,300,000 -133,000,000 -129,100,000 37,500,000 -99,000,000 2,200,000 
      effect of exchange rates on cash and cash equivalents
    -3,400,000 14,600,000 7,000,000 -18,100,000 10,000,000 -3,300,000 -5,700,000 7,400,000 -3,600,000 -5,800,000 2,900,000 12,000,000 -12,700,000 -12,700,000 -1,100,000 -4,800,000 -4,600,000 2,400,000 -6,200,000 11,900,000 6,600,000 3,600,000 -6,800,000 2,800,000 -6,500,000 1,100,000 1,100,000 -3,400,000 -4,100,000 -13,100,000 10,400,000 1,800,000 7,000,000 -12,500,000 1,500,000 -13,500,000 1,800,000 -400,000 -6,200,000 1,800,000 -17,800,000 -11,500,000 -11,800,000 2,600,000 2,400,000 -4,600,000 5,200,000 -9,300,000 -8,300,000 -2,500,000 7,200,000 -3,600,000 -8,400,000 -2,000,000 -200,000 -2,400,000 
      change in cash and cash equivalents
    735,800,000 -827,700,000 859,100,000  148,900,000 27,100,000 -22,700,000                                                  
      cash and cash equivalents, beginning of year
    525,500,000 415,800,000 375,700,000 478,500,000 802,100,000 617,900,000 542,800,000 524,400,000 634,100,000 1,459,300,000 1,083,300,000 1,080,600,000 884,300,000 768,300,000 
      cash and cash equivalents, end of period
    735,800,000 -827,600,000 1,384,500,000  148,900,000 27,100,000 393,000,000  -27,700,000 -10,400,000 330,200,000  159,000,000 -49,400,000 435,800,000 -441,100,000 -122,800,000 318,100,000 724,300,000 -165,200,000 253,900,000 -1,720,200,000 2,433,600,000 105,400,000 109,400,000 -183,700,000 586,800,000 18,200,000 43,400,000 -1,284,200,000 1,765,400,000 43,600,000 1,039,500,000 158,800,000 -501,000,000 -20,500,000 996,800,000 -7,600,000 42,300,000 -7,368,900,000 8,793,500,000  -1,400,000 86,000,000 882,700,000  207,500,000 52,900,000 657,000,000  150,500,000 -23,000,000 674,000,000    
      net proceeds from revolving facilities
         45,000,000 70,000,000                                                  
      cash flows from operating activities from continuing operations:
                                                            
      net earnings from continuing operations
           419,700,000 162,800,000 209,800,000 232,800,000 -130,200,000 194,200,000 154,000,000 73,200,000                                          
      adjustments to reconcile net earnings to net cash from operating activities:
                                                            
      goodwill and intangible asset impairment
                           975,900,000    272,000,000                         
      (gain) loss on investment in zimvie inc.
                                                          
      deferred income tax benefit
                                                            
      net cash from operating activities from continuing operations
           588,400,000 337,600,000 347,900,000 307,700,000 244,200,000 450,800,000 345,500,000 315,700,000                                          
      cash flows from investing activities from continuing operations:
                                                            
      net cash from investing activities from continuing operations
           -220,800,000 -165,600,000 -243,100,000 -149,400,000 -112,500,000 -85,200,000 -243,200,000 -81,100,000                                          
      cash flows from financing activities from continuing operations:
                                                            
      net (payments) proceeds on revolving facilities
                                                            
      proceeds from term loan
                                                       
      payments on term loans
                         -210,000,000 -325,000,000 -115,000,000 -310,000,000                              
      distribution from zimvie, inc.
               540,600,000                                          
      net cash from financing activities from continuing operations
           -251,400,000 -196,000,000 -109,400,000 -206,700,000 -313,400,000 -193,900,000 -146,000,000 -122,400,000                                          
      cash flows used in discontinued operations:
                                                            
      net cash from discontinued operations
               7,000,000 -153,800,000                                          
      increase in cash and cash equivalents
               -169,700,000 159,000,000   -441,100,000 -122,800,000 318,100,000 -77,800,000 -165,200,000 253,900,000 -1,720,200,000 1,815,700,000 105,400,000   44,000,000 18,200,000   1,241,000,000  405,400,000 158,800,000 -501,000,000 -20,500,000 -462,500,000 -7,600,000 42,300,000 -7,368,900,000 7,710,200,000 116,000,000    163,200,000    82,800,000 150,500,000 -23,000,000 -94,300,000 215,300,000 -249,700,000 252,000,000 
      cash and cash equivalents, end of year
                                                            
      payment on term loan
             -33,900,000                                              
      acquisition of intangible assets and other investing activities
                                                            
      acquisition of intellectual property rights
          -12,500,000 -13,100,000                                            -300,000 -2,900,000 
      loss on early extinguishment of debt
                                                            
      cash flows from discontinued operations:
                                                            
      adjustments to reconcile net earnings from continuing operations to cash from operating activities from continuing operations:
                                                            
      intangible asset impairment
                                   2,000,000                      
      distribution from zimvie inc.
                                                            
      proceeds from revolving facility
             200,000,000 370,000,000  120,000,000 100,000,000                                          
      payments on revolving facility
             -265,000,000 -160,000,000                                             
      decrease in cash and cash equivalents
             -10,400,000 -45,500,000    -42,700,000                             86,000,000 -197,900,000   52,900,000 -227,300,000        
      (gain) loss on investment in zimvie
              -2,500,000                                              
      loss on investment in zimvie
                                                            
      investments in other assets
                      -15,400,000 6,100,000 -13,500,000 -3,200,000 -11,600,000 16,700,000 -26,500,000 4,600,000 -14,500,000         -12,700,000 -14,700,000 -2,100,000 -10,200,000 -6,400,000 -3,000,000 4,700,000 -7,400,000   66,400,000 -5,500,000 -65,600,000 -8,800,000 39,800,000 -2,100,000 -19,800,000 -34,900,000 23,400,000 -8,900,000 -14,700,000 
      proceeds from multicurrency revolving facility
                               400,000,000 400,000,000                        
      payments on multicurrency revolving facility
                               -25,000,000                           
      net cash flows from unremitted collections from factoring programs
                       -15,000,000 -20,000,000 -32,000,000 12,400,000 3,200,000 10,200,000 -9,200,000 -16,400,000 17,900,000 8,300,000 -2,100,000 -60,800,000                          
      adjustments to reconcile net earnings from continuing operations to cash from operating activities:
                                                            
      proceeds from term loans
                           200,000,000                            
      net payments on other debt
                           -300,000    -3,700,000 -200,000                          
      goodwill impairment
                          612,000,000                                  
      changes in operating assets and liabilities, net of
                                                            
      acquired assets and liabilities
                                                            
      inventory step-up
                                  100,000 600,000 14,600,000 22,400,000 14,500,000 132,700,000 153,700,000 180,700,000 126,600,000 10,100,000 400,000 400,000 800,000 1,700,000 2,500,000 2,900,000 2,700,000 1,600,000 800,000  500,000 1,000,000 1,000,000 1,800,000 100,000 2,600,000 
      debt extinguishment
                                                            
      purchases of investments
                                     -100,000 -200,000 -900,000 -300,000 -35,800,000 -26,400,000 -152,600,000 -200,800,000 -366,800,000 -182,600,000 -600,700,000 -152,400,000 -214,300,000 -271,200,000 -94,800,000 -328,400,000 -264,200,000 -281,900,000 -255,600,000 -258,300,000 -312,700,000  
      sales of investments
                                     12,900,000 49,800,000 223,500,000 224,100,000 179,900,000 78,600,000 320,300,000 362,800,000 228,000,000 108,300,000 583,100,000 199,600,000 155,800,000 243,400,000 232,000,000 211,400,000 244,400,000 248,100,000 174,600,000 169,800,000 11,000,000  
      ldr acquisition, net of acquired cash
                                                           
      changes in operating assets and liabilities, net of effect of acquisitions:
                                                            
      accounts payable and accrued expenses
                                50,700,000 600,000 -27,700,000  -137,000,000  65,900,000 -21,200,000 -120,700,000  -347,300,000 245,300,000 -149,500,000  8,200,000 54,300,000 -56,000,000  -12,500,000 40,100,000 -31,300,000  19,700,000 14,200,000 -29,900,000    
      cash flows used in investing activities:
                                                            
      other business combination investments, net of acquired cash
                                      -237,800,000                      
      payments on term loan
                                -275,000,000 -225,000,000 -300,000,000 -150,000,000 -100,000,000 -200,000,000 -100,000,000 -400,000,000 -350,000,000                   
      restricted stock withholdings
                                -500,000 -300,000 -2,500,000 -700,000                         
      payments on senior notes
                                                            
      biomet merger consideration compensation expense
                                                            
      excess income tax benefit from stock option exercises
                                        -3,200,000 -1,500,000 -1,200,000 -1,300,000 -7,800,000 -1,400,000 -1,100,000 -3,200,000 -5,400,000 -1,300,000 -2,200,000 -1,600,000 -3,500,000 -400,000 -900,000 -200,000 -1,200,000 -1,000,000 -200,000 -300,000 
      gain on divestiture of assets
                                         -10,100,000 10,000,000                  
      deferred income tax provision
                                                            
      proceeds from divestiture of assets
                                         12,000,000 33,800,000                  
      biomet acquisition, net of acquired cash
                                                           
      net (payments) proceeds on other debt
                                    -700,000                        
      unremitted collections from factoring programs
                                                            
      restricted stock witholdings
                                    -5,200,000  -100,000                      
      proceeds from (payments on) senior notes
                                                            
      net proceeds (payments) under revolving credit facilities
                                                     99,800,000       
      income tax benefit from stock option exercises
                                        10,000,000 3,700,000 3,700,000 57,600,000 16,400,000 4,500,000 3,900,000 8,600,000 20,200,000 9,300,000 7,300,000 8,200,000 13,600,000 1,000,000 2,700,000 1,100,000 6,200,000 2,300,000 800,000 2,800,000 
      non-cash biomet merger consideration compensation expense
                                                           
      loss on divestiture of assets
                                                            
      net proceeds (payments on) under revolving credit facilities
                                                            
      net proceeds under revolving credit facilities
                                        300,000  -100,000 100,000 800,000           -146,700,000 1,000,000    
      biomet acquistion, net of acquired cash
                                                            
      business combination investments
                                                            
      income taxes payable
                                                            
      payment of senior notes
                                                            
      equity issuance costs
                                                            
      purchase of additional shares from noncontrolling interest
                                                          
      net payments under revolving credit facilities
                                              900,000 300,000 200,000  800,000          
      proceeds from issuance of notes
                                                            
      net (payments) proceeds under revolving credit facilities
                                                    -100,100,000        
      inventory step-up and other inventory charges
                                                            
      other business combination investments
                                                            
      net curtailment and settlement
                                                           
      acquisition of noncontrolling interest
                                                           
      net earnings of zimmer holdings, inc.
                                                          34,900,000 155,200,000 
      gain on sale of investments
                                                            
      in-process research and development
                                                            
      changes in operating assets and liabilities, net of acquired assets and liabilities income taxes payable
                                                            
      abbott spine acquisition, net of acquired cash
                                                            
      net borrowing under credit facilities
                                                            
      purchases of short-term investments
                                                            
      sales of short-term investments
                                                            
      purchases of certificates of deposit
                                                            
      sales of certificates of deposit
                                                            
      adjustments to reconcile net earnings to net cash provided
                                                            
      by operating activities:
                                                            
      proceeds from sale of investments
                                                            
      net proceeds (payments) under revolving credit facility
                                                            
      changes in operating assets and liabilities:
                                                            
      proceeds from sale of property, plant and equipment
                                                            
      other acquisitions, net of acquired cash
                                                            
      net borrowings under credit facilities
                                                            
      effect of exchange rates on cash and equivalents
                                                            
      increase in cash and equivalents
                                                            
      cash and equivalents, beginning of year
                                                            
      cash and equivalents, end of year
                                                            
      zimmer holdings, inc.
                                                            
      gain on sale of other assets
                                                            
      proceeds from sale of other assets
                                                            
      acquisitions, net of acquired cash
                                                            
      cash and equivalents, end of period
                                                            
      1.
                                                            
      net proceeds (payments) on lines of credit
                                                            
      for the years ended december 31,
                                                            
      other comprehensive income
                                                            
      foreign currency cumulative translation adjustments
                                                            
      unrealized foreign currency hedge gains/(losses), net of tax effects of 11.5 in 2007, 7.6 in 2006 and (17.8) in 2005
                                                            
      reclassification adjustments on foreign currency hedges, net of tax effects of (1.3) in 2007, (1.8) in 2006 and (12.7) in 2005
                                                            
      unrealized gains/(losses) on securities, net of tax effects of 0.9 in 2007, 0.9 in 2006 and 0.9 in 2005
                                                            
      prior service cost and unrecognized (gain)/loss in actuarial assumptions, net of tax effects of (0.4) in 2007
                                                            
      minimum pension liability adjustment, net of tax effects of (0.6) in 2006
                                                            
      comprehensive income
                                                            
      net proceeds on lines of credit
                                                            
      cash flows from (used in) operating activities:
                                                            
      cash flows from (used in) investing activities:
                                                            
      cash flows from (used in) financing activities:
                                                            
      share-based payment expense
                                                            
      centerpulse and incentive acquisitions, net of acquired cash
                                                            
      implex acquisition, net of acquired cash
                                                            
      proceeds from note receivable
                                                            
      other
                                                            
      zimmer holdings, inc. and subsidiaries
                                                            
      changes in operating assets and liabilities, net of acquired assets and liabilities:
                                                            
      proceeds from exercise of stock options
                                                            
      net payments on lines of credit
                                                            
      decrease in cash and equivalents
                                                            
      net earnings, as reported
                                                            
      deduct: total stock-based compensation expense determined under fair value based method for all awards, net of tax
                                                            
      pro forma net earnings
                                                            
      earnings per share:
                                                            
      basic — as reported
                                                            
      basic — pro forma
                                                            
      diluted — as reported
                                                            
      diluted — pro forma
                                                            
      changes in operating assets and liabilities, net of acquisitions:
                                                            
      basic - as reported
                                                            
      basic - pro forma
                                                            
      diluted - as reported
                                                            
      diluted - pro forma
                                                            
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.